M. M. Mouradian And NotRécepteur dopaminergique D2
List of bibliographic references
Number of relevant bibliographic references: 6.Ident. | Authors (with country if any) | Title |
---|---|---|
002166 | William Bara-Jimenez [États-Unis] ; Tzvetelina Dimitrova [États-Unis] ; Abdulah Sherzai [États-Unis] ; Antonella Favit [États-Unis] ; M. M. Mouradian [États-Unis] ; Thomas N. Chase [États-Unis] | Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease |
003416 | P. J. Blanchet [États-Unis] ; L. V. Metman [États-Unis] ; M. M. Mouradian [États-Unis] ; T. N. Chase [États-Unis] | Acute pharmacologic blockade of dyskinesias in Parkinson's disease |
003598 | L. V. Metman [États-Unis] ; V. H. Sethy ; J. R. Roberts ; D. Bravi ; J. I. Hoff ; M. M. Mouradian ; T. N. Chase | Motor effects of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine (Preclamol) in Parkinson's disease |
003614 | L. Verhagen Metman [États-Unis] ; J. Hoff ; M. M. Mouradian ; T. N. Chase | Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa |
003662 | D. Bravi [États-Unis] ; T. L. Davis ; M. M. Mouradian ; T. N. Chase | Treatment of Parkinson's disease with the partial dopamine agonist EMD 49980 |
003714 | M. E. Giuffra [États-Unis] ; V. H. Sethy ; T. L. Davis ; M. M. Mouradian ; T. N. Chase | Milacemide therapy for Parkinson's disease |
![]() | This area was generated with Dilib version V0.6.23. | ![]() |